Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2
Dysregulation of deubiquitination has been reported to contribute to carcinogenesis. However, the function and mechanism of deubiquitinating enzyme 26S proteasome non‐ATPase regulatory subunit 14 (PSMD14) in the progression of ovarian cancer (OV), the deadliest gynecological cancer, still remains to...
Guardado en:
Autores principales: | Tianshui Sun, Zhuonan Liu, Fangfang Bi, Qing Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d4589114cba4195aeec647c7216aa6a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PKM2 Is the Target of a Multi-Herb-Combined Decoction During the Inhibition of Gastric Cancer Progression
por: Qingmin Sun, et al.
Publicado: (2021) -
The Activation and Selectivity of the Legionella RavD Deubiquitinase
por: Eric Schulze-Niemand, et al.
Publicado: (2021) -
Iridin Prevented Against Lipopolysaccharide-Induced Inflammatory Responses of Macrophages via Inactivation of PKM2-Mediated Glycolytic Pathways
por: Ying ZH, et al.
Publicado: (2021) -
STEAP4 Inhibits HIF-1α/PKM2 Signaling and Reduces High Glucose-Induced Apoptosis of Retinal Vascular Endothelial Cells
por: Liu L, et al.
Publicado: (2020) -
CXCL14 facilitates the growth and metastasis of ovarian carcinoma cells via activation of the Wnt/β-catenin signaling pathway
por: Li-Na Gao, et al.
Publicado: (2021)